BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33726654)

  • 1. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
    Tepe M; Saylisoy S; Toprak U; Inan I
    Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions.
    Lemercier P; Paz Maya S; Patrie JT; Flors L; Leiva-Salinas C
    AJR Am J Roentgenol; 2014 Jul; 203(1):163-9. PubMed ID: 24951211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
    AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
    PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma.
    Yu H; Gao L; Shi R; Kong M; Duan L; Cui J
    Quant Imaging Med Surg; 2023 Jun; 13(6):3716-3725. PubMed ID: 37284107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.
    Baunin C; Schmidt G; Baumstarck K; Bouvier C; Gentet JC; Aschero A; Ruocco A; Bourlière B; Gorincour G; Desvignes C; Colavolpe N; Bollini G; Auqier P; Petit P
    Skeletal Radiol; 2012 Sep; 41(9):1141-9. PubMed ID: 22318350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases.
    Caravan I; Ciortea CA; Contis A; Lebovici A
    Acta Radiol; 2018 May; 59(5):599-605. PubMed ID: 28835111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
    Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.
    Beig Zali S; Alinezhad F; Ranjkesh M; Daghighi MH; Poureisa M
    Neuroradiol J; 2021 Jun; 34(3):205-212. PubMed ID: 33417503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of conventional magnetic resonance imaging and diffusion-weighted imaging in the differentiation of bone plasmacytoma from bone metastasis in the extremities.
    Hwang H; Lee SK; Kim JY
    Diagn Interv Imaging; 2021 Oct; 102(10):611-618. PubMed ID: 34127433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.
    Toh CH; Castillo M; Wong AM; Wei KC; Wong HF; Ng SH; Wan YL
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):471-5. PubMed ID: 18065516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
    Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
    Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
    Miquelini LA; Pérez Akly MS; Funes JA; Besada CH
    Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases.
    Han C; Huang S; Guo J; Zhuang X; Han H
    J Magn Reson Imaging; 2015 Jul; 42(1):80-6. PubMed ID: 25223489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.